Cargando…

Shared decision-making for prophylactic cranial irradiation in extensive-stage small-cell lung cancer: an exploratory study

BACKGROUND: Prophylactic cranial irradiation (PCI) offers extensive-stage small-cell lung cancer (ES-SCLC) patients a lower chance of brain metastasis and slightly longer survival but is associated with a short-term decline in quality of life due to side-effects. This tradeoff between survival and q...

Descripción completa

Detalles Bibliográficos
Autores principales: Ankolekar, Anshu, De Ruysscher, Dirk, Reymen, Bart, Houben, Ruud, Dekker, Andre, Roumen, Cheryl, Fijten, Rianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350106/
https://www.ncbi.nlm.nih.gov/pubmed/34430352
http://dx.doi.org/10.21037/tlcr-21-175
_version_ 1783735682346254336
author Ankolekar, Anshu
De Ruysscher, Dirk
Reymen, Bart
Houben, Ruud
Dekker, Andre
Roumen, Cheryl
Fijten, Rianne
author_facet Ankolekar, Anshu
De Ruysscher, Dirk
Reymen, Bart
Houben, Ruud
Dekker, Andre
Roumen, Cheryl
Fijten, Rianne
author_sort Ankolekar, Anshu
collection PubMed
description BACKGROUND: Prophylactic cranial irradiation (PCI) offers extensive-stage small-cell lung cancer (ES-SCLC) patients a lower chance of brain metastasis and slightly longer survival but is associated with a short-term decline in quality of life due to side-effects. This tradeoff between survival and quality of life makes PCI suitable for shared decision-making (SDM), where patients and clinicians make treatment decisions together based on clinical evidence and patient preferences. Despite recent clinical practice guidelines recommending SDM for PCI in ES-SCLC, as well as the heavy disease burden, research into SDM for lung cancer has been scarce. This exploratory study presents patients’ experiences of the SDM process and decisional conflict for PCI. METHODS: Radiation oncologists (n=7) trained in SDM applied it in making the PCI decision with ES-SCLC patients (n=25). We measured patients’ preferred level of participation (Control Preferences Scale), the level of SDM according to both groups (SDM-Q-9 and SDM-Q-Doc), and patients’ decisional conflict [decisional conflict scale (DCS)]. RESULTS: Seventy-nine percent of patients preferred a collaborative role in decision-making, and median SDM scores given by patients and clinicians were 80 (IQR: 75.6–91.1) and 85.2 (IQR: 78.7–88.9) respectively, indicating satisfaction with the process. However, patients experienced considerable decisional conflict. Over 50% lacked clarity about which choice was suitable for them and were unsure what to choose. Sixty-four percent felt they did not know enough about the harms and benefits of PCI, and 60% felt unable to judge the importance of the harms/benefits in their life. CONCLUSIONS: ES-SCLC patients prefer to be involved in their treatment choice for PCI but a substantial portion experiences decisional conflict. Better information provision and values clarification may support patients in making a choice that reflects their preferences.
format Online
Article
Text
id pubmed-8350106
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-83501062021-08-23 Shared decision-making for prophylactic cranial irradiation in extensive-stage small-cell lung cancer: an exploratory study Ankolekar, Anshu De Ruysscher, Dirk Reymen, Bart Houben, Ruud Dekker, Andre Roumen, Cheryl Fijten, Rianne Transl Lung Cancer Res Original Article BACKGROUND: Prophylactic cranial irradiation (PCI) offers extensive-stage small-cell lung cancer (ES-SCLC) patients a lower chance of brain metastasis and slightly longer survival but is associated with a short-term decline in quality of life due to side-effects. This tradeoff between survival and quality of life makes PCI suitable for shared decision-making (SDM), where patients and clinicians make treatment decisions together based on clinical evidence and patient preferences. Despite recent clinical practice guidelines recommending SDM for PCI in ES-SCLC, as well as the heavy disease burden, research into SDM for lung cancer has been scarce. This exploratory study presents patients’ experiences of the SDM process and decisional conflict for PCI. METHODS: Radiation oncologists (n=7) trained in SDM applied it in making the PCI decision with ES-SCLC patients (n=25). We measured patients’ preferred level of participation (Control Preferences Scale), the level of SDM according to both groups (SDM-Q-9 and SDM-Q-Doc), and patients’ decisional conflict [decisional conflict scale (DCS)]. RESULTS: Seventy-nine percent of patients preferred a collaborative role in decision-making, and median SDM scores given by patients and clinicians were 80 (IQR: 75.6–91.1) and 85.2 (IQR: 78.7–88.9) respectively, indicating satisfaction with the process. However, patients experienced considerable decisional conflict. Over 50% lacked clarity about which choice was suitable for them and were unsure what to choose. Sixty-four percent felt they did not know enough about the harms and benefits of PCI, and 60% felt unable to judge the importance of the harms/benefits in their life. CONCLUSIONS: ES-SCLC patients prefer to be involved in their treatment choice for PCI but a substantial portion experiences decisional conflict. Better information provision and values clarification may support patients in making a choice that reflects their preferences. AME Publishing Company 2021-07 /pmc/articles/PMC8350106/ /pubmed/34430352 http://dx.doi.org/10.21037/tlcr-21-175 Text en 2021 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Ankolekar, Anshu
De Ruysscher, Dirk
Reymen, Bart
Houben, Ruud
Dekker, Andre
Roumen, Cheryl
Fijten, Rianne
Shared decision-making for prophylactic cranial irradiation in extensive-stage small-cell lung cancer: an exploratory study
title Shared decision-making for prophylactic cranial irradiation in extensive-stage small-cell lung cancer: an exploratory study
title_full Shared decision-making for prophylactic cranial irradiation in extensive-stage small-cell lung cancer: an exploratory study
title_fullStr Shared decision-making for prophylactic cranial irradiation in extensive-stage small-cell lung cancer: an exploratory study
title_full_unstemmed Shared decision-making for prophylactic cranial irradiation in extensive-stage small-cell lung cancer: an exploratory study
title_short Shared decision-making for prophylactic cranial irradiation in extensive-stage small-cell lung cancer: an exploratory study
title_sort shared decision-making for prophylactic cranial irradiation in extensive-stage small-cell lung cancer: an exploratory study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350106/
https://www.ncbi.nlm.nih.gov/pubmed/34430352
http://dx.doi.org/10.21037/tlcr-21-175
work_keys_str_mv AT ankolekaranshu shareddecisionmakingforprophylacticcranialirradiationinextensivestagesmallcelllungcanceranexploratorystudy
AT deruysscherdirk shareddecisionmakingforprophylacticcranialirradiationinextensivestagesmallcelllungcanceranexploratorystudy
AT reymenbart shareddecisionmakingforprophylacticcranialirradiationinextensivestagesmallcelllungcanceranexploratorystudy
AT houbenruud shareddecisionmakingforprophylacticcranialirradiationinextensivestagesmallcelllungcanceranexploratorystudy
AT dekkerandre shareddecisionmakingforprophylacticcranialirradiationinextensivestagesmallcelllungcanceranexploratorystudy
AT roumencheryl shareddecisionmakingforprophylacticcranialirradiationinextensivestagesmallcelllungcanceranexploratorystudy
AT fijtenrianne shareddecisionmakingforprophylacticcranialirradiationinextensivestagesmallcelllungcanceranexploratorystudy